Industry News
Biotechnology Industry News
UPDATED: Merck’s oral COVID-19 antiviral slashes hospitalizations, prevents deaths in phase 3, sparking race to file with FDA
UPDATED: Merck's oral COVID-19 antiviral slashes hospitalizations, prevents deaths in phase 3, sparking race to file with FDA ntaylor Fri, 10/01/2021 - 06:49
Micreos lands $37M to show whether antibiotic alternative delivers in the clinic
Micreos lands $37M to show whether antibiotic alternative delivers in the clinic ntaylor Fri, 10/01/2021 - 06:08
AstraZeneca is nearly ready to seek approval for its COVID-19 antibody. Can it stick the landing?
AstraZeneca is nearly ready to seek approval for its COVID-19 antibody. Can it stick the landing? ntaylor Thu, 09/30/2021 - 08:52
Lilly adds liver fat, CGM blood sugar data to mountain of evidence on hot diabetes prospect tirzepatide
Lilly adds liver fat, CGM blood sugar data to mountain of evidence on hot diabetes prospect tirzepatide ntaylor Thu, 09/30/2021 - 07:44
Sunovion pens $890M Otsuka pact for a clutch of neuropsychiatric drugs
Sunovion pens $890M Otsuka pact for a clutch of neuropsychiatric drugs badams Thu, 09/30/2021 - 07:39
Researchers unravel the genetic cause of a childhood disorder and a potential way to prevent it with drugs
Researchers unravel the genetic cause of a childhood disorder and a potential way to prevent it with drugs klahucik Wed, 09/29/2021 - 13:23
Amicus spins off gene therapy unit in $600M SPAC deal as CEO becomes chief at Caritas
Amicus spins off gene therapy unit in $600M SPAC deal as CEO becomes chief at Caritas badams Wed, 09/29/2021 - 08:26
I-Mab hits the deal table with biopharma majors to talk partnerships and investments: report
I-Mab hits the deal table with biopharma majors to talk partnerships and investments: report ntaylor Wed, 09/29/2021 - 08:13
How exploiting a protective gene mutation might protect the brain from Alzheimer’s disease
How exploiting a protective gene mutation might protect the brain from Alzheimer's disease aliu Wed, 09/29/2021 - 06:13
How exploiting a protective gene mutation might shield the brain from Alzheimer’s disease
How exploiting a protective gene mutation might shield the brain from Alzheimer's disease aliu Wed, 09/29/2021 - 06:13
AstraZeneca moves deeper into rare diseases, spending $150M on late-phase hematology prospect
AstraZeneca moves deeper into rare diseases, spending $150M on late-phase hematology prospect ntaylor Wed, 09/29/2021 - 05:09
Shionogi licenses out 3rd-gen HIV asset to ViiV, notches a flop in chronic cough
Shionogi licenses out 3rd-gen HIV asset to ViiV, notches a flop in chronic cough badams Tue, 09/28/2021 - 08:53
Here we go again: Eisai starts rolling FDA approval submission for Biogen-partnered Alzheimer’s drug
Here we go again: Eisai starts rolling FDA approval submission for Biogen-partnered Alzheimer's drug ntaylor Tue, 09/28/2021 - 06:09
Valneva, hit by COVID contract chaos, sees Lyme disease vaccine drop-off in phase 2, but boosters helping
Valneva, hit by COVID contract chaos, sees Lyme disease vaccine drop-off in phase 2, but boosters helping badams Tue, 09/28/2021 - 05:18
After $3.2B deal, Sanofi dumps Translate’s mRNA COVID vaccine but hits the gas on switch to modified molecules
After $3.2B deal, Sanofi dumps Translate's mRNA COVID vaccine but hits the gas on switch to modified molecules ntaylor Tue, 09/28/2021 - 05:18
With a phase 3 fail, Biohaven learned the hard way why AstraZeneca dropped a CNS drug in 2018
With a phase 3 fail, Biohaven learned the hard way why AstraZeneca dropped a CNS drug in 2018 klahucik Mon, 09/27/2021 - 10:14
Novel ‘nanosized’ drug carriers tamp down HIV in the brain and other remote tissues in mice
Novel 'nanosized' drug carriers tamp down HIV in the brain and other remote tissues in mice arlene.weintraub Mon, 09/27/2021 - 09:49
Syndax and Incyte, both reeling from cancer drug setbacks, pen chronic graft-versus-host disease collab
Syndax and Incyte, both reeling from cancer drug setbacks, pen chronic graft-versus-host disease collab badams Mon, 09/27/2021 - 06:52
Mystery suitor lines up $11B Acceleron acquisition: report
Mystery suitor lines up $11B Acceleron acquisition: report ntaylor Mon, 09/27/2021 - 05:11
Pfizer stumbles close to finish line in growth hormone race, extending the lead of rival Ascendis
Pfizer stumbles close to finish line in growth hormone race, extending the lead of rival Ascendis ntaylor Mon, 09/27/2021 - 04:30